Peptide
Tesofensine
Triple reuptake weight loss
A triple monoamine reuptake inhibitor originally developed for Parkinson's that showed remarkable weight loss effects. Affects dopamine, serotonin, and norepinephrine.
Mechanisms
- Triple reuptake inhibition
- Appetite suppression
- Metabolic enhancement
Dosing
Typical dose
0.25–0.5mg
Timing
Oral daily dosing. Significant weight loss potential.